Click Sign-Up Today to register an account to access your prescriptions.
Please note: Your previous login credentials will not work with this new service.
Download our NEW Mobile App! See details below!
New Study Suggests No Major Adverse Outcomes With Early GLP-1 Exposure During Pregnancy
Researchers found no substantial increase in the risk of pregnancy loss, abnormal fetal growth, or major congenital malformations among pregnancies with first-trimester GLP-1 exposure. But they say more studies are needed.
Health News is provided as a service to Tinsley Bible Drug Co. site users by HealthDay. Tinsley Bible Drug Co. nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.